WTO obtains dismissal in antidepressant litigation

In two unrelated cases alleging harm caused by a popular antidepressant, we persuaded the plaintiffs to dismiss all of their claims against our client, a Fortune 100 pharmaceutical company, after summary judgment briefing and without any settlement payment to the plaintiffs. 
Persuaded plaintiffs to dismiss without settlement all claims involving an antidepressant manufactured by WTO's client, a Fortune 100 pharmaceutical company.